Segura S et al. |
Eczema herpeticum during treatment of atopic dermatitis with 1% pimecrolimus cream. |
2005 |
Acta Derm. Venereol. |
pmid:16396803
|
Mercader P et al. |
Treatment of protein contact dermatitis with topical tacrolimus. |
2005 |
Acta Derm. Venereol. |
pmid:16396818
|
Pagliarello C and Paradisi A |
Topical tacrolimus is useful for avoiding suction-blister epidermal grafting depigmentation in non-segmental vitiligo: a case report. |
2012 |
Acta Derm. Venereol. |
pmid:22101735
|
Hamade Y et al. |
Lichen planus in childhood showing various cutaneous features. |
2012 |
Acta Derm. Venereol. |
pmid:22101991
|
Nakamizo S et al. |
Treatment of neuropathic itch possibly due to trigeminal trophic syndrome with 0.1% topical tacrolimus and gabapentin. |
2010 |
Acta Derm. Venereol. |
pmid:21057761
|
Murota H et al. |
Olopatadine hydrochloride decreases tissue interleukin-31 levels in an atopic dermatitis mouse model. |
2014 |
Acta Derm. Venereol. |
pmid:23817562
|
Halvorsen JA and Aasebø W |
Oral tacrolimus treatment of pruritus in prurigo nodularis. |
2015 |
Acta Derm. Venereol. |
pmid:25804254
|
Remitz A et al. |
Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. |
2007 |
Acta Derm. Venereol. |
pmid:17225017
|
De Rie MA et al. |
Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1. |
1996 |
Acta Derm. Venereol. |
pmid:8891007
|
Pagliarello C et al. |
Topical tacrolimus and 50% zinc oxide paste for Hailey-Hailey disease: less is more. |
2012 |
Acta Derm. Venereol. |
pmid:22293917
|